Elsevier Inc.

SHERPA: Unknown

People

  1. Rusch
    Rusch
  2. Kris
    Kris
  3. Adusumilli
    Adusumilli
  4. Travis
    Travis
  5. Zauderer
    Zauderer
  6. Park
    Park
  7. Chaft
    Chaft
  8. Yorke
    Yorke
  9. Bains
    Bains
  10. Jones
    Jones

Groups

  1. Surgery (83)
  2. Department of Medicine (50)
  3. Solid Tumor Oncology Division (44)
  4. Thoracic Oncology (42)
  5. Survivorship Research (20)
  6. Radiation Oncology, Department of (15)
  7. GSK Faculty (14)
  8. Epidemiology and Biostatistics (12)
  9. Biostatistics Service (11)
  10. Medical Physics (10)
Search Within
  1. "Meeting abstract"
  2. "Valerie Rusch"
Formats
  1. Meeting Abstract (83)
Groups
  1. Surgery (83)
  2. Department of Medicine (50)
  3. Solid Tumor Oncology Division (44)
  4. Thoracic Oncology (42)
  5. Survivorship Research (20)
  6. Radiation Oncology, Department of (15)

More Groups

People
  1. Valerie Rusch (83)
  2. Mark Kris (24)
  3. Prasad Adusumilli (21)
  4. William Travis (21)
  5. Lee Krug (13)
  6. Marjorie Zauderer (13)

More People

Years
  1. 2023 (4)
  2. 2022 (2)
  3. 2021 (5)
  4. 2020 (1)
  5. 2019 (5)
  6. 2018 (2)

More Years

Publications
  1. Journal of Thoracic Oncology (66)
  2. International Journal of Radiation Oncology, Biology, Physics (14)
  3. European Journal of Cancer (1)
  4. Gastroenterology (1)
  5. Journal of Cardiothoracic and Vascular Anesthesia (1)

Results (83)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-risk clinicopathologic and genomic features of recurrence in stage I lung adenocarcinoma
    Meeting Abstract

    Fick, C. N.; Dunne, E. G.; Mastrogiacomo, B.; Tan, K. S.; Toumbacaris, N.; Adusumilli, P. S.; Rocco, G.; Molena, D.; Huang, J.; Park, B. J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes by age with neoadjuvant atezolizumab treatment for resectable non-small cell lung cancer in the phase 2 LCMC3 study
    Meeting Abstract

    Presley, C.; Owen, D. H.; Nicholas, A.; Hilz, S.; Oezkan, F.; Chaft, J. E.; Toloza, E. M.; Haura, E. B.; Patterson, A.; Waqar, S. N.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • The IASLC pleural mesothelioma staging project: Updated modeling of prognostic factors in pleural mesothelioma
    Meeting Abstract

    Wolf, A. S.; Rosenthal, A.; Giroux, D. J.; Nowak, A. K.; Bille, A.; de Perrot, M.; Kindler, H. L.; Rice, D.; Opitz, I.; Rusch, V. W.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Updated survival, efficacy and safety of adjuvant (adj) atezolizumab (atezo) after neoadjuvant (neoadj) atezo in the phase II LCMC3 study
    Meeting Abstract

    Carbone, D. P.; Waqar, S. N.; Chaft, J.; Kris, M. G.; Johnson, B. E.; Lee, J. M.; Wistuba, I. I.; Kwiatkowski, D.; Bunn, P. A.; Schulze, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Phase III randomized trial on surgery, chemo and pleural radiation (IMPRINT) for resectable pleural mesothelioma (NRG LU-006)
    Meeting Abstract

    Rimner, A.; Hu, C.; Simone, C. B. 2nd; Rusch, V. W.; Zauderer, M. G.; Gill, R. R.; Yorke, E. D.; Li, Z.; Voong, K. R.; Peikert, T.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • T-cell dynamics in response to neoadjuvant atezolizumab in early NSCLC by antigen response and T-cell receptor sequencing
    Meeting Abstract

    Oezkan, F.; Hilz, S.; Grindheim, J.; Wallace, A.; Seweryn, M.; Reuben, A.; Zhang, J.; Owen, D. H.; Nicholas, A.; Yadav, M.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • LCMC3: Immune cell subtypes predict nodal status and pathologic response after neoadjuvant atezolizumab in resectable NSCLC
    Meeting Abstract

    Oezkan, F.; Seweryn, M.; Pietrzak, M.; Byun, W. Y.; Owen, D.; Schulze, K.; Nicholas, A.; Hilz, S.; Grindheim, J.; Johnson, A.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Constructing a global molecular database for thoracic malignancies: The IASLC Molecular Subcommittee Lung Cancer dataset
    Meeting Abstract

    Osarogiagbon, R.; Nishimura, K.; Rami Porta, R.; Montuenga, L.; Giroux, D.; Suda, K.; Araujo, L.; Detterbeck, F.; Gautschi, O.; Kerr, K.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Meeting Abstract

    Hubbeling, H. G.; Choudhury, N.; Falcon, C.; Rusch, V. W.; Park, B.; Ziv, E.; Shaverdian, N.; Gelblum, D.; Shepherd, A. F.; Simone, C. B. 2nd; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • A Phase III randomized trial of pleurectomy/decortication plus chemotherapy with or without adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for malignant pleural mesothelioma (MPM) (NRG LU-006)
    Meeting Abstract

    Rimner, A.; Hu, C.; Rusch, V. W.; Gill, R. R.; Simone, C. B. 2nd; Zauderer, M.; Yorke, E. D.; Li, Z.; Peikert, T. D.; Voong, R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save